FDA's 2026 general wellness guidance narrows device regulation for low-risk trackers but leaves significant privacy, security, and litigation risks.
| less than a minute read
FDA's 2026 Guidance on General Wellness Devices: Policy for Low-Risk Devices

/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-03-18-20-38-34-305-69bb0d4a101695027f6f1189.jpg)
/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-03-18-20-37-42-566-69bb0d165e0a53b6d9b250e2.jpg)
/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-03-18-20-36-59-119-69bb0cebe00002bb2c6b6f62.jpg)
/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-03-18-20-35-05-232-69bb0c795e0a53b6d9b24e9c.jpg)